3D093 2025/03/06 13:15 °ìÈÌ¹Ö±é ¥Ý¥¹¥¿¡¼¡¦Å¸¼¨²ñ¾ì Æý»À¶ÝLP22A-3¤Î¥¢¥ì¥ë¥®¡¼À±ê¾ÉÍÞÀ©¸ú²Ì The oral administration of Lactiplantibacillus plantarum (LP22A-3) suppresses an allergic inflammation ³¤Ìî ¶Á±û²Â1¶áß· ̤Êâ1úɸ¶ ¹ÀÀ¿2ÅÄÀî ³Ù2»³Ì¾ Èþ¹¾2¿åÌî ²í»Ë3¡ûÌ« ·ò°ìϺ1Kyoka UNNO1 Miho CHIKAZAWA1 Hiroshige KUWAHARA2 Takashi TAGAWA2 Yoshie YAMANA2 Masashi MIZUNO3 ¡ûKenichiro MINATO1 1̾¾ëÂçÇÀ¡¢2´ÝÁ±À½ÌôÁí¹ç¸¦µæ½ê¡¢3ÂçºåÀÄ»³Âç·ò¹¯²Ê³Ø 1Meijo Univ., 2Maruzen Pharmaceuticals Co., 3Osaka Aoyama Univ. Lactiplantibacillus plantarum / anti-inflammation / allergy